Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine.
Lorenzo Villa Zapata, PhD
Advertisement
Articles by Lorenzo Villa Zapata, PhD
The authors explore the economic impact and accessibility challenges of new Alzheimer disease drugs under the Inflation Reduction Act, with emphasis on Medicare, pricing, and health care equity.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Clinician Shortages, Access Gaps Challenge Rural Primary Care
3
Diet, Lifestyle Come Into Focus for Managing Multiple Sclerosis: Rebecca Spain, MD
4
Guselkumab Shows Sustained 48-Week Protection Against Joint Damage in PsA
5
